Lindsay Rosenwald Accomplishments
Lindsay Rosenwald started his professional research at Pennsylvania State University in 1973 after graduating from Abington High School. He excelled an enterprise and was particularly intrigued with economics and finance.
In quest for his lifelong dream, Rosenwald entered Temple University’s University of Medicine. After graduating from Temple University in 1983, he began an internship at Abington Hospital before starting his own private practice. After filling out his internship, he worked as a health-care professional in his very own practice for 2.5 years. Even though he cherished being a medical doctor, Rosenwald preferred a career where he could blend his two loves – medical science and business enterprise.
Rosenwald quit his private practice in 1986 to go to Wall Street where he took on a position as a Physician / Analyst, an extremely exclusive position with just a few people doing it at that time. Despite the belief that doctors don’t make good investors, Dr Rosenwald excelled at this position. He had a passion for improving investment finance open to the health care sector and that is primarily why he worked there. People admired him and respected his opinions and knowledge. Even though he missed treating individuals, he recognized this was exactly where he belonged. During this time, he also worked for DH Blair and Company, a private investment organization, as the managing director of corporate finance. Over time, he left D.H. Blair and Company to pay attention to a new venture and firm.
Over time, he has broadened this company by starting new companies and attaining control of other biotech companies. The organization has financed more than two dozen companies within the last three years. He creates these companies by concentrating on the growth of both the corporate and biotechnology portions. All of these firms are separate entities, but interact to support one another. The firms that Rosenwald handles have licensed or acquired over a hundred experimental stage drugs.
One of the most notable accomplishments for Lindsay Rosenwald is setting the record for the speediest acceptance of a new drug to market. In merely thirty months, Arsenic Trioxide was created and approved by the FDA for the treatment of a deadly form of leukemia. This drug has been in the marketplace around the world for over ten years and has saved and prolonged 1000s of lives.
Rosenwald has created really groundbreaking companies one of his companies sold to J&J for more than One Billion Dollars even though they only had 1 drug with phase 2 data. He has also founded the very first publicly traded stem cell company, gene therapy company, and cancer vaccine company. As Rosenwald as the leader, his firms have created probably the most valuable and groundbreaking drug treatments of the 21st century. To add to his achievements he comes up with the very first successful medicine to aid those who are obese.
One of the reasons that Rosenwald’s companies have been profitable is that he hires PhDs, MDs, MBAs, and other experts to serve as his senior level professionals. These people usually have experience in business, however they also tend to possess vast knowledge in the medical community. They are driven to produce new drugs as soon as possible. Some of these medicines have the possibility to change the way we look at medical care entirely today. He has also created the Rosenwald Foundation that has contributed millions of dollars to health care and science instruction to help create the future of medicine.
Lindsay Rosenwald has built his business by constantly looking towards the future and now is no different. He speculates that over the next 20 years the biotech industry will continue to enlarge exponentially. Rosenwald predicts that major biotech breakthroughs of the future will come from smaller, startup biotech companies instead of the massive biotech firms we see these days. He feels the two most pressing problems we face today are heart disease and cancer.
Related posts:
May 28th, 2010 at 9:39 am
It is inspiring to see that there are so many achievements from one person in this touch industry. It requires excellent vision and power to stick to one idea and make it his life. He contributed 20 years to bio tech industry. His belief is that he concentrated mostly on medium sized companies instead of large scale companies. This is where he stands apart from other investors.
June 8th, 2010 at 5:36 am
this is the best person whom we can quote as an example to show case what can actually the interest of a person can do for him, it is the thing that the every individual in a society should basically have